<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antihypertensive Drug Classes | Cardiovascular Pharmacology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true
        },
        svg: { fontCache: 'global' }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="topic-01-hypertension-diuretics.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Hypertension & Diuretics</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">02</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">06</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 33%;"></div>
                            </div>
                            <span class="progress-label">Antihypertensive Drug Classes</span>
                        </div>
                        
                        <a href="topic-03-heart-failure.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Heart Failure</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item"><a href="../index.html">Cardiovascular System</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Antihypertensives</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">üíä</span>
                        <span class="badge-text">Pharmacology Module</span>
                    </div>
                    <h1 class="document-title">Antihypertensive Drug Classes</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üë§</span>
                            <span>PAUL KWASI -RN</span>
                        </span>
                        <span class="meta-item">
                            <span class="meta-icon">‚è±Ô∏è</span>
                            <span>25 min read</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">
                    
                    <!-- START: antihypertensive-overview -->
                    <section id="antihypertensive-overview" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üéØ</span>
                                Drug Targets & Classification
                            </h2>
                        </div>
                        
                        <div class="content-card">
                            <p>antihypertensive drugs, potential drug targets;</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">CNS: decrease sympathetic tone</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Heart: decrease cardiac out put</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Veins: dilate; decrease preload</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">arterioles: dilate; decrease preload</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Kidneys: increase diuresis; inhibit renin angiotensin aldosterone</span>
                                </li>
                            </ul>

                            <h3 id="classification-summary">Classification of anti hypertensives</h3>
                            <div class="collapsible-section">
                                <details class="collapsible-section" open>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        <span class="trigger-text">Major Drug Classes</span>
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>‚Ä¢ Diuretics:</p>
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Thiazide and related agents (hydrochlorothiazide, chlorthalidone)</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Loop diuretics (furosemide, bumetanide,, torsemide, ethacrynic)</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Potassium sparing diuretics (amiloride, triamterene, spironolactone)</span></li>
                                        </ul>
                                        
                                        <p>‚Ä¢ Angiotensin-converting enzyme (ACE) inhibitors ( captopril, enalapril, lisinopril, quinapril, Ramipril, benazepril)</p>
                                        
                                        <p>‚Ä¢ Angiotensin II receptor blockers (ARBS)</p>
                                        <p>(losartan, candesartan, Irbesartan, valsartan, telmisartan, eprosartan)</p>
                                        
                                        <p>‚Ä¢ Calcium channel blockers (CCB)</p>
                                        <p>(verapamil, diltiazem, nifedipine, felodipine, nicardipine, isradipine, amlodipine)</p>
                                        
                                        <p>Vasodilators</p>
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Arterial ( hydralazine, minoxidil, diazoxide fenoldopam)</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Arterial and venous (nitroprusside)</span></li>
                                        </ul>
                                        
                                        <p>Sympatholytic drugs</p>
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Alpha adrenergic blockers; (prazosin, terazosin, doxazosin, phentolamine, phenoxybenzamine)</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Beta adrenergic blockers; (metoprolol, atenolol, etc )</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Mixed adrenergic; ( labetalol, carvedilol)</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Centrally acting alpha2 agonists (methyldopa, clonidine, guanabenz)</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Adrenergic neuron blocking agents;( guanethidine, reserpine)</span></li>
                                        </ul>
                                    </div>
                                </details>
                            </div>
                        </div>
                    </section>
                    <!-- END: antihypertensive-overview -->

                    <!-- START: ace-inhibitors -->
                    <section id="ace-inhibitors" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Angiotensin-Converting Enzyme (ACE) Inhibitors
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>captopril (Capoten)</strong></p>
                            <p>‚Ä¢ Other Medications: Enalapril (Vasotec), Enalaprilat (Vasotec IV), Fosinopril (Monopril), Lisinopril (Prinivil), Ramipril (Altace)</p>

                            <h3 id="ace-mechanism">Mechanism of action</h3>
                            <p>ACEIs prevents conversion of angiotensin I to angiotensin II which is a potent vasoconstrictor. this causes vasodilation, reduces peripheral resistance, and decreases secretion of aldosterone (thereby resulting in decrease sodium and water retention and extracellular volume)</p>

                            <h3 id="ace-merits">Merits of ACEIs</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Safe for asthmatics, diabetics</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Absence of rebound hypertension upon abrupt withdrawal.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Total absence of postural hypotension.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">maintains renal blood flow.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">devoid of electrolyte imbalance.</span></li>
                            </ul>

                            <h3 id="ace-uses">Therapeutic Uses</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Hypertension</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Heart failure</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Myocardial infarction (To decrease mortality and to decrease risk of heart failure and left ventricular dysfunction)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Diabetic and nondiabetic nephropathy</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">For clients at high risk for a cardiovascular event, Ramipril can be used to prevent MI, stroke, or death.</span></li>
                            </ul>

                            <h3 id="ace-side-effects">Side/Adverse Effects</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Cough related to inhibition of kinase II (alternative name for ACE) which results in increase in bradykinin</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">First-dose orthostatic hypotension.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Hyperkalemia</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Rash and dysgeusia (altered taste), primarily with captopril</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Angioedema.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Neutropenia (rare but serious complication of captopril)</span></li>
                            </ul>

                            <h3 id="ace-contraindications">Contraindications/Precautions</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">These medications are Pregnancy Risk Category D during the second and third trimester, related to fetal injury.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">renal stenosis when present bilaterally or in a single remaining kidney.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">history of angioedema following use of ACE inhibitor.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Use cautiously in clients with renal impairment and</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">collagen vascular disease because they are at greater risk for developing neutropenia. Closely monitor these clients for signs of infection.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">hypotension</span></li>
                            </ul>

                            <h3 id="ace-interactions">Medication/Food Interactions</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Diuretics can contribute to first-dose hypotension</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Antihypertensive medications may have an additive hypotensive effect.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Potassium supplements and potassium-sparing diuretics increase the risk of hyperkalemia.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">ACE inhibitors can increase levels of lithium carbonate (Eskalith)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Use of NSAIDs may decrease the antihypertensive effect of ACE inhibitors.</span></li>
                            </ul>

                            <aside class="callout callout--note" role="note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìã</span>
                                    <span class="callout-title">Nursing Administration</span>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Administer ACE inhibitors orally except enalapril, which is the only ACE inhibitor for IV use.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Advise clients that the medication may be prescribed as a single formulation or in combination with hydrochlorothiazide.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Advise clients that blood pressure has to be monitored after the first dose for at least 2 hr. to detect hypotension.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Instruct clients that captopril should be taken at least 1 hr. before meals. All other ACE inhibitors can be taken with or without food.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Advise clients to notify the provider if cough, rash, dysgeusia (lack of taste), and/or signs of infection occur</span></li>
                                    </ul>
                                </div>
                            </aside>
                        </div>
                    </section>
                    <!-- END: ace-inhibitors -->

                    <!-- START: arbs -->
                    <section id="arbs" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Angiotensin II Receptor Blockers (ARBs)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>‚Ä¢ losartan (Cozaar)</p>
                            <p>‚Ä¢ Other Medications: Valsartan (Diovan) , Irbesartan (Avapro) , Candesartan (Atacand) , Olmesartan (Benicar)</p>

                            <h3 id="arbs-action">Expected Pharmacological Action</h3>
                            <p>These medications block the action of angiotensin II in the body.</p>
                            <p>This results in:</p>
                            <p>‚Ä¢ Vasodilation (mostly arteriole)</p>
                            <p>‚Ä¢ Excretion of sodium and water, and retention of potassium (through effects on the kidney)</p>

                            <h3 id="arbs-uses">Therapeutic Uses :</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Hypertension,</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Heart failure and prevention of mortality following MI,</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Stroke prevention ,</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Delay progression of diabetic nephropathy</span></li>
                            </ul>

                            <h3 id="arbs-complications">Complications</h3>
                            <p>The major difference between ARBs and ACE inhibitors is that cough and hyperkalemia are not side effects of ARBs</p>
                            <p>Side/Adverse Effects</p>
                            <p>‚Ä¢ Angioedema</p>

                            <h3 id="arbs-contraindications">contraindication</h3>
                            <p>‚Ä¢ Hypersensitivity</p>
                            <p>‚Ä¢ Pregnancy</p>
                            <p>‚Ä¢ renal stenosis when present bilaterally or in a single remaining kidney</p>

                            <h3 id="arbs-considerations">considerations</h3>
                            <p>monitor BP, HR, Weight, Edema, Blood Urea Nitrogen, Serum Creatinine.</p>
                            <p>Can be used in patients intolerant to ACEI‚Äôs (due to cough)</p>
                        </div>
                    </section>
                    <!-- END: arbs -->

                    <!-- START: calcium-channel-blockers -->
                    <section id="calcium-channel-blockers" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö°</span>
                                CALCIUM CHANNEL BLOCKERS
                            </h2>
                        </div>

                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Nifedipine (Adalat, Procardia)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Verapamil (Calan)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Amlodipine (Norvasc)</span></li>
                            </ul>
                            <p>Other Medications:</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Amlodipine (Norvasc)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Felodipine (Plendil)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Nicardipine (Cardene, Cleviprex)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Diltiazem (Cardizem)</span></li>
                            </ul>

                            <h3 id="ccb-mechanism">Mechanism of action of CCB</h3>
                            <p>‚Ä¢ inhibits calcium influx in the smooth muscles and the myocardium.</p>
                            <p>‚Ä¢ Blocking of calcium channels in blood vessels leads to vasodilation of peripheral arterioles and arteries/arterioles of the heart, slows down heart conduction and reduction of blood pressure.</p>

                            <div class="collapsible-section">
                                <details class="collapsible-section" open>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        <span class="trigger-text">NIFEDIPINE (ADALAT)</span>
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>‚Ä¢ give rise to coronary vasodilation.</p>
                                        <p>‚Ä¢ Enhances coronary blood flow.</p>
                                        <p>‚Ä¢ Reduces total periphery resistance, reduces systolic and diastolic pressure</p>
                                        
                                        <h4>Therapeutic use</h4>
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Chronic angina</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Congestive heart failure</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Acute myocardial infarction</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Peripheral vascular disorders</span></li>
                                        </ul>
                                        
                                        <h4>Adverse drug reaction</h4>
                                        <p>Palpitation, nausea, vomiting, flushing, headache, edema.</p>
                                    </div>
                                </details>
                            </div>

                            <div class="collapsible-section">
                                <details class="collapsible-section" open>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        <span class="trigger-text">amlodipine</span>
                                    </summary>
                                    <div class="collapsible-content">
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Serves as a long acting calcium channel blocker.</span></li>
                                        </ul>
                                        
                                        <h4>Therapeutic use</h4>
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Treatment of essential hypertension.</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Angina pectoris</span></li>
                                        </ul>
                                        
                                        <h4>Adverse drug reaction</h4>
                                        <p>Palpitation,epixtasis,cough,nocturia,musclecramps,breathless,importen ce, conjunctivitis</p>
                                    </div>
                                </details>
                            </div>

                            <div class="collapsible-section">
                                <details class="collapsible-section" open>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        <span class="trigger-text">verapamil</span>
                                    </summary>
                                    <div class="collapsible-content">
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Enhances coronary blood flow rate,vasodilation.</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Exerts anti arrhythmic action.</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Reduces peripheral resistance.</span></li>
                                        </ul>
                                        
                                        <h4>Therapeutic uses</h4>
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Supraventricular tachycardia.</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Acute coronary spasms</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Angina pectoris</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Hypertension with myocardial infarction</span></li>
                                        </ul>
                                        
                                        <h4>Adverse reaction</h4>
                                        <ul class="enhanced-list">
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Dizziness</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Vertigo</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Constipation</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Hypotension</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Nausea</span></li>
                                            <li class="list-item"><span class="list-marker"></span><span class="list-content">Pedal edema</span></li>
                                        </ul>
                                    </div>
                                </details>
                            </div>

                            <aside class="callout callout--note" role="note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìã</span>
                                    <span class="callout-title">Nursing considerations</span>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Monitor BP, HR, rhythm,</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Control calcium supplement.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Inform patient not to stop drug abruptly.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Patient to report signs of adverse effects such as irregular heart beat, shortness of breath, oedema in the hands and feet, dizziness, constipation, nausea and hypotension.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Discontinue in breast feeding because they are excreted in breast milk and have potential for adverse effects in neonates.</span></li>
                                    </ul>
                                </div>
                            </aside>
                        </div>
                    </section>
                    <!-- END: calcium-channel-blockers -->

                    <!-- START: direct-vasodilators -->
                    <section id="direct-vasodilators" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                DIRECT ACTING VASODILATORS
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3 id="hydralazine">HYDRALAZINE</h3>
                            <p>Hydralazine (APRESOLINE) causes direct relaxation of the arterio smooth muscle secondary to a fall in the intracellular calcium. this is associated with powerful stimulation of the sympathetic nervous system, due to baroreceptor mediated reflexes</p>

                            <h4 id="hydralazine-toxicity">Toxicity and precaution</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">These includes; headache, nausea, flushing, hypotension, palpitation, tachycardia, dizziness and angina pectoris.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Myocardial ischemia (increased oxygen demand)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Immunological reactions, drug induced lupus syndrome. this occurs after six months of treatment with hydralazine.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">symptoms include, arthralgia, arthritis and fever.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">The treatment can result in an illness that resembles serum sickness, hemolytic anaemia, vasculitis, and glomerulonephritis.</span></li>
                            </ul>

                            <h4 id="hydralazine-uses">Therapeutic uses</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Due to adverse effect profile, hydralazine is no longer a first line drug in the treatment of hypertension.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Used in patients with CCF(in combination with nitrates for patients who cannot tolerate ACE inhibitors.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Treatment of hypertension emergencies in pregnancy.</span></li>
                            </ul>
                            <p>(especially preeclampsia).</p>
                            <p>The usual dose is twenty five to 100mgs twice a day</p>
                            <p>The maximum recommended dose of hydralazine is 200mg/day.</p>

                            <h4 id="hydralazine-contraindication">Contraindication</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Parenteral administration in coronary artery disease.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Elderly patients</span></li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: direct-vasodilators -->

                    <!-- START: alpha-blockers -->
                    <section id="alpha-blockers" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üîí</span>
                                ALPHA ADRENERGIC BLOCKERS (SYMPATHOLYTICS)
                            </h2>
                        </div>

                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Medication: prazosin (Minipress)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">doxazosin mesylate (Cardura)</span></li>
                            </ul>

                            <h3 id="alpha-action">Expected Pharmacological Action</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">It inhibits Alpha adrenergic receptor causing Venous and arterial dilation leading to reduction in total peripheral vascular resistance.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Smooth muscle relaxation of the prostatic capsule and bladder neck</span></li>
                            </ul>

                            <h3 id="alpha-uses">Therapeutic uses</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Primary hypertension.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Doxazosin mesylate (Cardura) may be used to decrease symptoms of benign prostatic hypertrophy (BPH), which include urgency, frequency, and dysuria.</span></li>
                            </ul>

                            <h3 id="alpha-side-effects">Side/Adverse Effects</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">First-dose orthostatic hypotension</span></li>
                            </ul>

                            <h3 id="alpha-contraindications">Contraindications/Precautions</h3>
                            <p>‚Ä¢ Pregnancy</p>
                            <p>‚Ä¢ Clients with hypersensitivity to medication</p>
                            
                            <h3 id="alpha-interactions">Medication/Food Interactions Nursing Interventions/Client Education</h3>
                            <p>‚Ä¢ NSAIDs and clonidine may decrease the antihypertensive effects of prazosin.</p>
                            <p>‚Ä¢ Advise clients to avoid OTC NSAIDs.</p>

                            <aside class="callout callout--note" role="note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìã</span>
                                    <span class="callout-title">Nursing Administration</span>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Obtain baseline blood pressure and heart rate.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Instruct clients that the medication can be taken with food.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Recommend that clients take the initial dose at bedtime to decrease "first-dose" hypotensive effect.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Start treatment with low dosage of medication.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">First dose may be given at night.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Monitor blood pressure for 2 hr . after the initiation of treatment.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Instruct clients to avoid activities requiring mental alertness for the first 12 to 24 hr .</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Instruct clients to change positions slowly and to lie down if feeling dizzy, lightheaded, or faint</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Antihypertensive medications may have an additive hypotensive effect, instruct clients to observe for signs of hypotension (dizziness, lightheadedness, faintness).</span></li>
                                    </ul>
                                </div>
                            </aside>
                        </div>
                    </section>
                    <!-- END: alpha-blockers -->

                    <!-- START: central-alpha2-agonists -->
                    <section id="central-alpha2-agonists" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß†</span>
                                CENTRALLY ACTING ALPHA2 AGONISTS
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3 id="clonidine">clonidine (Catapres)</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">guanfacine HCl (Tenex),</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">methyldopa (Aldomet)</span></li>
                            </ul>

                            <h4 id="central-action">Expected Pharmacological Action</h4>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">These medications act within the CNS to decrease sympathetic outflow resulting in decreased stimulation of the adrenergic receptors (both alpha and beta receptors) of the heart and peripheral vascular system.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Decrease in sympathetic outflow to the myocardium results in bradycardia and decreased cardiac output (CO).</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Decrease in sympathetic outflow to the peripheral vasculature results in vasodilation, which leads to decreased blood pressure.</span>
                                </li>
                            </ul>

                            <h4 id="central-uses">Therapeutic Uses</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Primary hypertension (administered alone, with a diuretic, or with another antihypertensive agent)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Severe cancer pain (administered parenterally by epidural infusion)</span></li>
                            </ul>

                            <h4 id="central-investigational">Investigational use</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Migraine headache</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Flushing from menopause</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Management of ADHD and Tourette's syndrome</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Management of withdrawal symptoms from alcohol, tobacco, and opioids</span></li>
                            </ul>

                            <h4 id="central-side-effects">Side/Adverse Effects</h4>
                            <p>‚Ä¢ Drowsiness and sedation</p>
                            <p>‚Ä¢ Dry mouth</p>
                            <p>‚Ä¢ Rebound hypertension</p>

                            <h4 id="central-contraindications">contraindication</h4>
                            <p>‚Ä¢ Clonidine is Pregnancy Risk Category C.</p>
                            <p>‚Ä¢ Avoid use during lactation.</p>
                            <p>‚Ä¢ This medication is contraindicated for clients taking anticoagulant medications</p>
                            <p>‚Ä¢ Avoid use of transdermal patch on affected skin in scleroderma and systemic lupus erythematosus (SLE).</p>
                            <p>‚Ä¢ Use cautiously in clients with cerebrovascular disease, recent MI, diabetes mellitus, major depressive disorder, or chronic renal failure</p>
                            
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Antihypertensive medications may have an additive hypotensive effect.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Concurrent use of prazosin (Minipress), MAOI s, and tricyclic antidepressants can counteract the antihypertensive effect of clonidine.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Additive CNS depression can occur with concurrent use of other CNS depressants, such as alcohol.</span>
                                </li>
                            </ul>

                            <aside class="callout callout--note" role="note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìã</span>
                                    <span class="callout-title">Nursing Administration</span>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Administer medication by oral, epidural, and transdermal routes.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Medication is usually administered twice a day in divided doses. Take larger dose at bedtime to decrease the occurrence of daytime sleepiness.</span></li>
                                        <li class="list-item"><span class="list-marker"></span><span class="list-content">Transdermal patches are applied every seven days. Advise clients to apply patch on hairless, intact skin on torso or upper arm.</span></li>
                                    </ul>
                                </div>
                            </aside>

                            <h3 id="methyldopa">Methyldopa (ALDOMET)</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Acts through its metabolites (methylnorepinephrine)which stimulates central alpha adrenergic receptors, thus reducing total peripheral resistance.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">It does not affect glomerular filtration, cardiac output or heart rate.</span></li>
                            </ul>

                            <h4 id="methyldopa-effects">Therapeutic effects</h4>
                            <p>moderate to severe hypertension</p>

                            <h4 id="methyldopa-adverse">Adverse effects:</h4>
                            <p>GIT upsets, sedation, depression, nasal stuffiness, myocarditis edema, orthostatic hypotension, diarrhea, dry mouth, erectile dysfunction, eosinophilia, hemolytic anemia, fever.</p>

                            <h4 id="methyldopa-contraindication">contraindication</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Hypersensitivity, activity liver disease, those who developed liver cirrhosis with previous treatment of methyldopa.</span></li>
                            </ul>

                            <h4 id="methyldopa-caution">Caution;</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Patients taking diuretics and antihypertensive.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Those taking levodopa because of potential for additive antihypertensive effects.</span></li>
                            </ul>

                            <h4 id="methyldopa-consideration">Consideration</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">patient to avoid hazardous task.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Lower dose in impaired renal disease.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Monitor liver functions.</span></li>
                            </ul>

                            <h4 id="methyldopa-caution-cont">Caution cont.'</h4>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Monitor HB, RBCs for signs of anemia.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Monitor weight, fluid input and out put.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Signs of drug induced depression,</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Take BP in different patients position during dose adjustments, warn of signs and symptoms of adverse effects and toxicity</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Tolerance may develop 2to 3 weeks after start of treatment.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Urine may darken on exposure to air(as drug is broken down to its metabolites)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Dose increase should be made with the evening dose to minimize the effects of drowsiness.</span></li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: central-alpha2-agonists -->

                    <!-- START: beta-blockers -->
                    <section id="beta-blockers" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõ°Ô∏è</span>
                                BETA ADRENERGIC BLOCKERS (SYMPATHOLYTICS)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Cardioselective: Beta1</p>
                            <p>‚Ä¢ Metoprolol (Lopressor)</p>
                            <p>‚Ä¢ Atenolol (Tenormin)</p>
                            <p>‚Ä¢ Metoprolol succinate (Toprol XL)</p>
                            <p>‚Ä¢ Esmolol HCL (Brevibloc)</p>
                            <p>Nonselective: (Beta1 and Beta2)</p>
                            <p>‚Ä¢ Propranolol (Inderal)</p>
                            <p>‚Ä¢ Nadolol (Corgard)</p>
                            <p>‚Ä¢ Labetalol (Normodyne)</p>

                            <h3 id="beta-action">Expected Pharmacological Action</h3>
                            <p>They block beta- adrenergic receptors in the myocardium and in the electrical conduction system of the heart.</p>
                            <p>‚Ä¢ Decreased heart rate</p>
                            <p>‚Ä¢ Decreased myocardial contractility</p>
                            <p>‚Ä¢ Decreased rate of conduction through the AV node</p>

                            <h3 id="beta-uses">Therapeutic Uses</h3>
                            <p>hypertension , Angina, arrhythmias, heart failure and myocardial infarction.</p>
                            <p>Other uses may include: Treatment of hyperthyroidism, migraine headache, pheochromocytoma, and glaucoma</p>

                            <h3 id="beta-adverse">adverse effects</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Bradycardia, fatigue, dizziness, nightmares, depression, memory loss, hallucination, impotence, cold extremities, elevated serum cholesterol.</span></li>
                            </ul>

                            <h3 id="beta-contraindication">Contraindication</h3>
                            <p>severe hypotension, bradycardia, congestive heart failure, asthma, diabetics, critically abnormal lipid profile</p>

                            <h3 id="beta-consideration">Consideration</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Explain the rationale of therapy and importance of taking drugs as prescribed.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Patient should not discontinue drugs abruptly because it can cause MI or angina</span></li>
                            </ul>

                            <h3 id="beta-consideration-cont">Consideration cont.'</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Advise clients to avoid sudden changes in position to prevent occurrence of orthostatic hypotension</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Administer medications orally, usually once or twice a day.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Administer the following medications by IV route: atenolol, metoprolol, labetalol, propranolol.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Teach clients to self monitor heart rate and blood pressure at home on a daily basis.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Monitor weight &amp; signs of hypovolemic shock especially in diabetic patients.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Glucagon is prescribed to reverse signs of overdose.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Dose are lowered in geriatrics due to delayed metabolism and enhanced side effects.</span></li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: beta-blockers -->

                    <!-- START: hypertensive-crisis -->
                    <section id="hypertensive-crisis" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">09</div>
                            <h2 class="section-title">
                                <span class="title-icon">üöë</span>
                                Medications for Hypertensive Crisis
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>nitroprusside sodium (Nitropress)</p>
                            <p>Other Medications:</p>
                            <p>Nitroglycerin (Nitrostat IV)</p>
                            <p>Nicardipine (Cardene)</p>
                            <p>Clevidipine (Cleviprex)</p>
                            <p>Enalaprilat (Vasotec IV)</p>
                            <p>Esmolol HCL (Brevibloc)</p>

                            <h3 id="crisis-mechanism">mechanism of Action</h3>
                            <p>Direct vasodilation of arteries and veins resulting in rapid reduction of blood pressure (decreased preload and afterload) ‚óè Therapeutic Uses Hypertensive emergencies</p>

                            <h3 id="crisis-side-effects">Side effects</h3>
                            <p>Excessive hypotension</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Administer medication slowly because rapid administration will cause blood pressure to go down rapidly.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Monitor the client's blood pressure and ECG.</span></li>
                            </ul>

                            <h3 id="crisis-interactions">Interactions</h3>
                            <p>Nitroprusside should not be administered in the same infusion as any other medication.</p>

                            <aside class="callout callout--note" role="note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìã</span>
                                    <span class="callout-title">Nursing Administration</span>
                                </div>
                                <div class="callout-content">
                                    <p>‚Ä¢ Prepare medication by adding to diluent for IV infusion.</p>
                                    <p>‚Ä¢ Note color of solution. Solution may be light brown in color. Discard solution of any other color.</p>
                                    <p>‚Ä¢ Protect IV container and tubing from light.</p>
                                    <p>‚Ä¢ Discard medication after 24 hr.</p>
                                    <p>‚Ä¢ Monitor vital signs and ECG continuously</p>
                                </div>
                            </aside>
                        </div>
                    </section>
                    <!-- END: hypertensive-crisis -->

                    <!-- Key Points Section -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>ACEIs prevents conversion of angiotensin I to angiotensin II which is a potent vasoconstrictor.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Cough related to inhibition of kinase II (alternative name for ACE) which results in increase in bradykinin.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>The major difference between ARBs and ACE inhibitors is that cough and hyperkalemia are not side effects of ARBs.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Blocking of calcium channels in blood vessels leads to vasodilation of peripheral arterioles and arteries/arterioles of the heart.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Nitroprusside should not be administered in the same infusion as any other medication.</strong></p>
                                </li>
                            </ul>
                        </div>
                    </aside>
                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="topic-01-hypertension-diuretics.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Hypertension & Diuretics</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="topic-03-heart-failure.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Heart Failure</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>